Skip to main content

Day: January 4, 2021

The Ensign Group Acquires Three Skilled Nursing Facilities in Southern California

SAN JUAN CAPISTRANO, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) — The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the EnsignTM group of companies, which provide skilled nursing and assisted living services, physical, occupational and speech therapies and other rehabilitative and healthcare services, announced today that it acquired the operations of three skilled nursing facilities in Southern California. The acquisitions were effective January 1, 2021 and will be subject to a long-term, triple net lease. The acquisitions include:Golden Hill Post Acute, a skilled nursing facility with 99 skilled nursing beds located in San Diego, CA;St. Catherine Healthcare, a skilled nursing facility with 99 skilled nursing beds located in Fullerton, CA; andCamino Healthcare, a skilled nursing facility with 99 skilled nursing beds located...

Continue reading

Transaction to combine Husky and Cenovus closes

CALGARY, Alberta, Jan. 04, 2021 (GLOBE NEWSWIRE) — Husky Energy is pleased to announce the transaction to strategically combine with Cenovus Energy has closed.The transaction was completed through a definitive arrangement agreement announced on October 25, 2020 under which Cenovus and Husky agreed to combine in an all-stock transaction. Pursuant to the transaction agreement, Husky common shareholders received 0.7845 of a Cenovus common share and 0.0651 of a Cenovus common share purchase warrant in exchange for each Husky common share. In addition, Husky preferred shareholders exchanged each Husky preferred share for one Cenovus preferred share with substantially identical terms.Cenovus common shares remain listed on the Toronto Stock Exchange (TSX) and New York Stock Exchange (NYSE) under the ticker symbol CVE. The Cenovus warrants...

Continue reading

Zomedica Appoints Robert Cohen CEO as Company Nears Commercialization of TRUFORMA™

ANN ARBOR, Mich., Jan. 04, 2021 (GLOBE NEWSWIRE) — Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced the appointment of Robert Cohen as Chief Executive Officer effective January 1, 2021. Mr. Cohen previously served as the Company’s Interim CEO and as a member of the Board of Directors.Mr. Cohen brings to Zomedica more than 30 years of executive leadership and operations experience from the medical device, biotechnology and pharmaceutical industries. Following his earlier tenure at three multi-billion-dollar medical technology companies, Mr. Cohen built shareholder value at a series of smaller organizations as Chief Executive Officer. The Board of Directors recruited Mr. Cohen due to his successful track record...

Continue reading

cBrain leverer F2 til Danmarks Miljøportal

Fondsbørsmeddelelse nr. 01/2021cBrain leverer F2 til Danmarks MiljøportalKøbenhavn, 4. januar 2021Danmarks Miljøportal, som er et fællesoffentligt partnerskab ejet af staten, kommunerne og regionerne, har valgt at indføre F2 som digital platform.cBrain kan med stor tilfredshed notere en fortsat fremgang på det danske marked, hvor stadig flere myndigheder indfører F2. I 2019 kunne cBrain således annoncere aftaler med bl.a. Erhvervsministeriets departement, Hjemrejsestyrelsen og Københavns Kommune.Mere end 75 danske myndigheder anvender i dag standardsystemet F2, og den fortsatte fremgang i Danmark er vigtig for cBrain, ikke mindst fordi en stærk position på det danske hjemmemarked er vigtig for eksporten.Det er derfor glædeligt, at Danmarks Miljøportal nu indfører F2. Det underbygger cBrains fortsatte succes og fremgang i Danmark.F2 leveres...

Continue reading

Condom Market to Reach USD 9.90 Billion by 2027; Growing Knowledge about Deadly STDs to Spur Sales Opportunities, states Fortune Business Insights™

Pune, India, Jan. 04, 2021 (GLOBE NEWSWIRE) — The global condom market size is expected to reach USD 9.90 billion by 2027, exhibiting a CAGR of 9.3% during the forecast period. The growing awareness regarding STDs such as, hepatitis B, Syphilis, trichomoniasis, and chlamydia can fuel demand for condoms, which, in turn, will aid the expansion of the market, states Fortune Business Insights, in a report, titled “Condom Market Size, Share & COVID-19 Impact Analysis, By Type (Male and Female), Material (Latex and Non-latex), Distribution Channel (Mass Merchandisers, Drug Stores, Online, and Others), and Regional Forecast, 2020-2027.” The market size stood at USD 4.48 billion in 2019.The coronavirus incident has caused colossal loss to several industries across the globe. The governments of several countries have instigated lockdown...

Continue reading

36Kr Holdings Inc. to Participate in Upcoming Virtual Investor Conferences

BEIJING, Jan. 04, 2021 (GLOBE NEWSWIRE) — 36Kr Holdings Inc. (“36Kr” or the “Company” or “We”) (NASDAQ: KRKR), a prominent brand and a pioneering platform dedicated to serving New Economy participants in China, today announced its participation in the following virtual investor conferences:Morgan Stanley China New Economy Summit, January 6-8, 2021Needham 23rd Annual Growth Conference, January 11-15, 2021Management will meet online with institutional investors throughout these events. For additional information, please contact your respective institutional sales representative at each sponsoring bank.About 36Kr Holdings Inc.36Kr Holdings Inc. is a prominent brand and a pioneering platform dedicated to serving New Economy participants in China with the mission of empowering New Economy participants to achieve more. The Company started...

Continue reading

TLC Announces Completion of US$15 Million Financing for Subsidiary InspirMed Inc.

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Jan. 04, 2021 (GLOBE NEWSWIRE) — TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, announced today that its subsidiary, InspirMed Inc., has completed a round of financing, raising US$15 million in cash from strategic investors in exchange for subsidiary equity.InspirMed is a newly established subsidiary of TLC specializing in the development of inhalable liposome formulation programs, such as TLC19 for the treatment of Coronavirus disease 2019 (COVID-19) as well as other programs for severe acute and chronic pulmonary diseases. The strategic move to partition lung disease programs from TLC will allow TLC to maintain focus on its current pipeline of liposomal injectable formulation programs,...

Continue reading

INVESTORS HOUSE: YLI 4500 VUOKRATTUA ASUNTOA – KASVU JATKUU VAKAANA

Investors House Oyj                                                                          Lehdistötiedote 4.1.2021 klo 12:00Investors House: Yli 4500 vuokrattua asuntoa – kasvu jatkuu vakaanaInvestors House -konserniin kuuluva OVV-ketju vuokrasi joulukuussa yhteensä 316 asuntoa, mikä on noin prosentin enemmän kuin edellisvuoden vastaavan ajankohdan 313 asuntoa. Vuositasolla 1-12/2020 OVV-ketjun vuokraamien asuntojen määrä 4512 asuntoa on sekin edellisvuoden 4491 asunnon tasoa korkeampi.”Vuosi 2020 oli monin tavoin poikkeuksellinen. Vaikutukset asuntomarkkinaan jäivät kuitenkin vähäisiksi, minkä myös OVV-ketjun kasvaneet vuokrausmäärät osoittavat. Useissa maakuntakeskuksissa on edelleen vuokralaisen markkinat asuntojen ylitarjonnasta johtuen, kun taas pääkaupunkiseudulla väestönkasvu pitää markkinatilanteen paremmin tasapainossa. Tästä...

Continue reading

DSV, 853 – SHARE BUYBACK IN DSV PANALPINA A/S

Company Announcement No. 853On 29 October 2020, we initiated a share buyback programme, as described in Company Announcement No. 842 of 29 October 2020. According to the programme, the company will in the period from 29 October 2020 to 30 April 2021 purchase own shares up to a maximum value of DKK 6,000,000,000 and no more than 12,000,000 shares, corresponding to 5.22% of the share capital at commencement of the programme. The programme has been implemented in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules.As at today, DSV Panalpina A/S holds a total of 3,893,822 shares of a nominal value of DKK 1 in DSV Panalpina A/S, corresponding to 1.69% of the total number of issued shares of 230,000,000.The...

Continue reading

Blue Vision A/S status: Erstatningskrav varslet – Tilgodehavende

Dato: 04. januar 2021 Årets meddelelse nr.: 2                                             Varslet erstatningskravDen 30. august 2019 indgik Blue Vision A/S en betinget aftale med en række sælgere for så vidt angår Blue Visions A/S’ køb via apportindskud af Heartcare ApS og dets døtreselskaber Contra A/S og Aktiv Integration ApS.  Den 30. september 2019 vedtog generalforsamlingen transaktionen. Sælgerne af Heartcare ApS modtog 4.000.000 aktier svarende til en værdi på DKK 16,0 mil. for apportindskuddet af Heartcare ApS. I årsrapporten for 2019, offentliggjort den 31. marts 2020, nedskrives værdien af Heartcare-investeringen til DKK 0,0.Ved selskabsmeddelelse nr. 13 af den 31. december 2020 har Blue Vision A/S informeret om, at der forventes hensættelser til afvikling på mere en DKK 10,0 mil. for så vidt angår Heartcare-aktiviteterne.Den...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.